← Eichor
Study identifier: NCT07012759 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pleural Effusion Biomarkers in Lung Adenocarcinoma Patients

Condition: Biomarkers · Lung Adenocarcinoma · Pleural Effusion  ·  Sponsor: Fu Jen Catholic University

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This project aims to assess the expression levels of novel molecular markers identified through screening in clinical samples of malignant pleural effusion, to evaluate the feasibility and clinical utility of these markers as potential diagnostic genes for lung adenocarcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Ke-Yun Chao, PhD  ·  +886905301879  ·  ck_qq@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Fu Jen Catholic University Hospital, Fu Jen Catholic UniversityNew Taipei City, TaiwanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07012759